Val drugs9 Jul 2018 12:34
I am as worried about the placement of more shares as the next shareholder, and I was livid on Friday when the rns first came out. My main frustration is that the last placement was as I understood it, to get them through a few months cash burn prior to a deal.
Bearing this in mind, val cannot negotiate a deal without the potential to raise funds to keep themselves going, or a pharma will just play hard ball until they have to sign the deal on the table. With the recent changes in language and commercial update I am willing to vote yes and hope for the deal to be signed on the back of this, and hope there is no further placing required.
As hard as they make it, let's not forget the drugs we have are already proven to work, and on the back of recent news from FARN, IMM, N4P this value and fact should not be underestimated